Posts filtered by tags: Lancet[x]


 

A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world data suggests

Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. Irfan Khan / Los Angeles Times via Getty Images One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study. The COVID-19 vaccine's protection increased to 85% in those who got two shots. The data showed Pfizer's vaccine worked against a mutated va...
Tags: Health, UK, Science, Cdc, Scotland, Israel, US, Trends, Healthcare, Pfizer, Vaccine, Phe, Pcr, Lancet, Centers for Disease Control and Prevention CDC, Massaro


A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world UK data suggests

Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California. Irfan Khan / Los Angeles Times via Getty Images One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study. The COVID-19 vaccine's protection increased to 85% in those who got two shots. The data showed Pfizer's vaccine worked against a mutated va...
Tags: Health, UK, Science, Cdc, Scotland, Israel, US, Trends, Healthcare, Pfizer, Vaccine, Phe, Pcr, Lancet, Centers for Disease Control and Prevention CDC, Massaro


"A single shot of the [Pfizer] vaccine is 85% effective in preventing symptomatic disease 15 to 28 days after being administered..."

"... according to a peer-reviewed study conducted by the Israeli government-owned Sheba Medical Center and published in the Lancet medical journal. Pfizer and BioNTech recommend that a second dose is administered 21 days after the first. The finding is a vindication of the approach taken by the U.K. government to delay a second dose by up to 12 weeks so it could use limited supplies to deliver a single dose to more people, and could encourage others to follow suit.... "The Wall Street Journal r...
Tags: Law, Pfizer, Wall Street Journal, Lancet, Ann Althouse, Sheba Medical Center, Coronavirus


Lancet Study Finds 40% of US COVID-19 Deaths Could Have Been Avoided (slashdot)

phalse phace shares a report from Slate: The British medical journal the Lancet, on Wednesday, published a damning assessment of Donald Trump's presidency and its impact on Americans' health, concluding that 40 percent of the nearly 500,000 COVID-19 deaths in the U.S. over the past year were avoidable. The journal came to the conclusion by comparing the U.S. health outcomes on the coronavirus -- the country leads the world in COVID deaths and confirmed cases with more than 27 million -- with the...
Tags: News, US, Donald Trump, Lancet, Trump, BeauHD, COVID


Lancet Study Finds 40% of US COVID-19 Deaths Could Have Been Avoided

phalse phace shares a report from Slate: The British medical journal the Lancet, on Wednesday, published a damning assessment of Donald Trump's presidency and its impact on Americans' health, concluding that 40 percent of the nearly 500,000 COVID-19 deaths in the U.S. over the past year were avoidable. The journal came to the conclusion by comparing the U.S. health outcomes on the coronavirus -- the country leads the world in COVID deaths and confirmed cases with more than 27 million -- with the...
Tags: US, Tech, Donald Trump, Lancet, Trump, COVID


ICE has no plan to vaccinate 13,860 immigrants in its custody against COVID-19. Here's how one of the US's most at-risk groups is falling through the cracks.

US Immigration and Customs Enforcement; Samantha Lee/Insider Experts say incarcerated people should be among the first to receive the COVID vaccine. But ICE has no plan to vaccinate detainees, an Insider investigation has found. Experts raised concerns that thousands of detained immigrants were falling through the cracks. Visit Insider's homepage for more stories. When US Immigration and Customs Enforcement agents arrested Giovannie Morrison in October, the pandemic was burning through hi...
Tags: Florida, Politics, New York, Texas, Minnesota, Justice, Maryland, Congress, Colorado, California, Cdc, Washington, Germany, Boston, Massachusetts, New York City


Damning analysis of Trump's pandemic response suggested 40% of US COVID-19 deaths could have been avoided

Donald Trump removes his mask upon return to the White House from Walter Reed National Military Medical Center on October 5, 2020 in Washington, DC. Win McNamee/Getty Images A report on the Trump administration's public-health policies suggested 40% of US COVID-19 deaths were avoidable.  Compared to six similarly wealthy countries, the US failed to protect citizens' health during the pandemic. Trump publicly downplayed COVID-19 and often undermined health guidelines. Visit the Business sec...
Tags: Politics, UK, Science, News, Cdc, Washington, White House, US, Trends, Cnn, Atlantic, Oklahoma, Donald Trump, Anthony Fauci, Centers For Disease Control And Prevention, Lancet


AstraZeneca's missteps and murky data sewed worldwide confusion that undermined trust - but don't rule the shot out yet

A medical staffer vaccinates a colleague with the AstraZeneca vaccine at the South Ile-de-France Hospital Group in Melun, France on February 8, 2021. Thomas Samson/AFP/Getty Images AstraZeneca's coronavirus vaccine could be anywhere from 22% to 90% effective, depending on the parameters. Doses might be more effective given 12 weeks apart. Experts say inconsistency in AstraZeneca's trials and data might be undermining trust in the shots. Visit the Business section of Insider for more storie...
Tags: Europe, UK, Science, London, News, Sweden, US, Trends, European Union, South Africa, Washington Dc, Italy, Belgium, Brazil, World Health Organization, Astrazeneca


COVID-19: New variants raise worry over reinfections

By Marilynn Marchione | Associated Press Evidence is mounting that having COVID-19 may not protect against getting infected again with some of the new variants. People also can get second infections with earlier versions of the coronavirus if they mounted a weak defense the first time, new research suggests. How long immunity lasts from natural infection is one of the big questions in the pandemic. Scientists still think reinfections are fairly rare and usually less serious than initial ones, bu...
Tags: New York, California, Los Angeles, Sport, Ap, Soccer, United States, South Africa, Brazil, Johannesburg, Anthony Fauci, Lancet, Mount Sinai, New England Journal of Medicine, Manaus, Fauci


Fauci explains why you should keep wearing a face mask after receiving a COVID-19 shot

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, on June 30, 2020. Al Drago/AFP via Getty Images People should keep wearing masks after getting a COVID-19 vaccine, Dr. Anthony Fauci said Thursday. "We do not have enough data to be able to say with confidence vaccines can prevent transmission," Fauci said. People who have received their vaccines in trials are being followed up to figure this out. Visit the Business section of Insider for more stories...
Tags: Health, US, Trends, Joe Biden, Healthcare, Food And Drug Administration, Astrazeneca, Pfizer, Vaccine, University of Oxford, Johnson, Mask, Anthony Fauci, Lancet, Fauci, Johns Hopkins University


The leader of Russia's COVID-19 vaccine program says the shot won't be available in the US or UK any time soon

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, a co-developer of the Sputnik V vaccine RDIF The Russian coronavirus vaccine probably won't be available in the US or UK any time soon. The shot was 91.6% effective at preventing COVID-19, according to data published Tuesday. Going through the US regulatory process is "not frankly a priority for us,"  Kirill Dmitriev, CEO of the Russian Direct Investment Fund told Insider. Visit Business Insider's homepage for more stories. Russia...
Tags: Health, Europe, UK, Science, News, Vladimir Putin, Germany, Angela Merkel, Russia, US, Trends, European Union, Healthcare, Sputnik, Astrazeneca, University of Oxford


Russia's Sputnik V Vaccine Is Just as Good as Western Shots, Study Finds

The findings, published in the British medical journal the Lancet, will help it tamp down the skepticism that has surrounded Russia’s effort.
Tags: Russia, Lancet


Russia coronavirus vaccine 91.6% effective: Lancet - Business Insider

The Lancet has published an interim analysis of phase 3 trial data from the Sputnik V vaccine. Russia approved the shot in August 2020.
Tags: Russia, Lancet


Russian coronavirus vaccine achieves over 90 percent efficacy: Lancet

The clinical trial also analyzed people over 60 and found the jab was 91.8 percent effective.
Tags: Lancet


Covaxin is well tolerated with no adverse side-effects, says Lancet after Phase 1 trail

It adds, Covaxin binds and induces neutralising antibody responses. The post Covaxin is well tolerated with no adverse side-effects, says Lancet after Phase 1 trail appeared first on NextBigWhat.
Tags: Business, Lancet, Covaxin, News on Chai, Covid-19 News


Prisoners are 5 times more likely to get COVID-19 than the overall population. A 69-year old prisoner is trying to change that one livestream at a time.

The COVID-19 pandemic is tearing through US prisons, with inmates 5.5 times more likely to catch the disease than the overall population. One prisoner under home confinement, 69-year-old Rufus Rochelle, is calling for the release of prisoners in daily Facebook Live streams. Correctional facilities are desperately lacking PPE and other health resources, and can hardly enforce social distancing measures. Visit Business Insider's homepage for more stories. On the evening that Rufus Rochelle saw th...
Tags: Facebook, Video, New York, News, Prison, Congress, California, Washington, US, Trends, Chicago, Criminal Justice System, United States, Williams, Aclu, Connecticut


Pollution killed nearly 1.7m people in India in 2019 – study

Lancet report finds that toxic air caused rise in lung cancer, stroke and other diseasesPollution accounted for nearly 1.7m premature deaths in India in 2019, or 18% of all deaths, according to a study that lays bare the human cost of the country’s toxic urban air.A report published by the Lancet says pollution in India has led to an increase in diseases such as lung cancer, heart disease, stroke, diabetes, neonatal disorders and respiratory diseases, resulting in millions more deaths. Continue ...
Tags: India, Environment, World news, Air Pollution, South and Central Asia, Pollution, Lancet


The coronavirus was circulating in Europe and China months before officials identified the outbreak in Wuhan, studies show

A man walks past a billboard that reads "All together, without fear," in Naples, Italy, March 22, 2020. Carlo Hermann /AFP/Getty December 31 marks the anniversary of the first confirmed coronavirus cases in Wuhan. But a growing body of evidence suggest the virus was circulating in China and some European countries months before that. In the US, meanwhile, a study found that some people had coronavirus antibodies in December 2019. Visit Business Insider's homepage for more stories. Almost e...
Tags: Health, Europe, Science, Milan, News, Washington, France, China, US, Trends, Spain, Genetics, Harvard University, Paris, Italy, Middle East


COVID vaccines are here, but big questions remain about immunity, mandates

Nurse Annabelle Jimenez, left, congratulates nurse Sandra Lindsay after she is inoculated with the Pfizer-BioNTech COVID-19 vaccine, Monday, Dec. 14, 2020, at the Jewish Medical Center, in the Queens borough of New York. (AP Photo/Mark Lennihan, Pool) Whoops of celebration, crackling applause and tears of joy erupted as the first health care workers were jabbed with the coronavirus vaccine last week, kicking off the largest mass vaccination campaign in history. After their second dose, will th...
Tags: Apple, New York, News, Sweden, Supreme Court, California, Stanford, Massachusetts, San Francisco, Sport, Ap, Public Health, Soccer, Queens, Cambridge, Astrazeneca


One chart shows how well Pfizer's vaccine works

Hollis Johnson/Business Insider Hello,Today in healthcare news: One chart shows just how well Pfizer and BioNTech's vaccine works at preventing COVID-19, our most detailed look at AstraZeneca and Oxford's vaccine data, and a Verily cofounder's plan to address one of the most overlooked parts of caring for patients. ACOB KING/POOL/AFP via Getty Images One striking chart shows just how well Pfizer's vaccine works to prevent COVID-19 infections The Food and Drug Administration releas...
Tags: US, Trends, Atlantic, Healthcare, Oxford, Argentina, Astrazeneca, Fda, Pfizer, University of Oxford, Cvs, Lancet, Verily, The Food and Drug Administration, The Lancet, BioNtech


United States: Fires And Floods, Holiday Version - Foley Hoag LLP

The Lancet's Countdown on Health and Climate Change for 2020 offers some a pretty sobering assessment of the impacts of climate change
Tags: News, United States, Foley Hoag, Lancet


We just got our most-detailed look yet at the safety and effectiveness of the Oxford-AstraZeneca coronavirus vaccine. Here's what you need to know.

AstraZeneca's COVID-19 vaccine results have been published and can be scrutinized. Joe Raedle/Getty Images AstraZeneca is the first COVID-19 vaccine-maker to publish results from late-stage trials in a peer-reviewed journal.  The results, published in the Lancet on Tuesday, suggest the vaccine's efficacy is 70%, on average. The data confirmed preliminary results announced on November 23. The shot hasn't been signed off by regulators, but the data has been submitted and is under review....
Tags: UK, Trends, South Africa, Oxford, Brazil, Astrazeneca, Pfizer, University of Oxford, Oxford University, Lancet, Pollard, UK Brazil, Andrew Pollard, Moderna, Mene Pangalos, Pangalos


Oxford AstraZeneca Covid vaccine has 70% efficacy, full trial data shows

Newly published data shows 90% efficacy only in small group who got half-dose firstCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford AstraZeneca Covid vaccine has efficacy of 90% in a small group who got a half-dose first, but only 62% in the majority, full trial data newly published in the Lancet has confirmed.The results may create a quandary for regulatory bodies, which will have to decide on how the vaccine should be used if they approve it. Continue reading...
Tags: Health, UK News, Oxford, Astrazeneca, Vaccines and immunisation, Lancet, Coronavirus


Oxford Covid vaccine 'safe and effective' study shows

The peer-reviewed work in the Lancet medical journal confirms the vaccine is 'safe and protects'.
Tags: UK, News, Lancet


Global analysis tracks the impact of climate change on human health

Unless we take urgent action to tackle climate change, we can expect an ever-hotter world that threatens global health, disrupts lives and livelihoods and overwhelms healthcare systems, according to The Lancet's Global Countdown on Health and Climate Change, a comprehensive global analysis tracking the impact of climate change on human health across 41 key indicators.
Tags: Health, Lancet


Mailman School experts contribute to new Lancet report on health and climate change

Unless we take urgent action to tackle climate change, we can expect an ever-hotter world that threatens global health, disrupts lives and livelihoods and overwhelms healthcare systems, according to The Lancet's Global Countdown on Health and Climate Change, a comprehensive global analysis tracking the impact of climate change on human health across 41 key indicators.
Tags: Science, Lancet, Mailman School


Bill Gates just released a plan for US leadership on climate change, including $35B in funding

Bill Gates, the co-founder of Microsoft and one of the world’s richest men and most prolific philanthropists, has just released a broad new plan on how the U.S. could take the lead in the fight against climate change. “[We] need to revolutionize the world’s physical economy—and that will take, among other things, a dramatic infusion of ingenuity, funding, and focus from the federal government. No one else has the resources to drive the research we need,” Gates writes.  With a new Biden ad...
Tags: TC, Microsoft, Congress, Climate Change, Senate, US, Tech, Georgia, Nasa, Bill Gates, National Institutes of Health, Biden, Department Of Energy, Gates, Lancet, National Public Radio


No country, rich or poor, is immune from the health effects of climate change

A changing climate threatens to undermine the past 50 years of gains in public health The post No country, rich or poor, is immune from the health effects of climate change appeared first on The Mail & Guardian.
Tags: Climate Change, Environment, Public Health, Air Pollution, Wildfires, Agriculture, Heatwaves, Lancet, Food Insecurity, Paris Agreement, Top Six, World Meteorological Organisation, South Africa (country, PM2.5, James Irlam, Alice McGushin


Oxford/AstraZeneca vaccine to undergo new global trial

Share price drops as critics question claim vaccine could protect up to 90% of peopleWhat tier am I in? Latest Covid rules in England post-lockdownCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University/AstraZeneca vaccine will undergo a new global trial as critics questioned the claim that it could protect up to 90% of people against coronavirus.On Thursday Sir John Bell, Oxford’s regius professor of medicine and the UK government’s life sciences adviser, dismissed sug...
Tags: Health, UK, England, Science, UK News, World news, Medical Research, Vaccines and immunisation, University of Oxford, Lancet, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca, John Bell Oxford


Oxford/AstraZeneca vaccine results face growing scrutiny

Share price drops as critics question claim vaccine could protect up to 90% of peopleWhat tier am I in? Latest Covid rules in England post-lockdownCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University/AstraZeneca vaccine is coming under increasing scrutiny, with critics questioning the claim that trials showed it could protect up to 90% of people against coronavirus.On Thursday Sir John Bell, Oxford’s regius professor of medicine and the UK government’s life sciences ...
Tags: UK, England, Science, UK News, World news, Lancet, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca, John Bell Oxford